Company News Archives

2 03, 2023

Avance Biosciences™ licenses SeQure Dx’s GUIDE-seq off-target NGS analysis technology
Gallery

Avance Biosciences™ licenses SeQure Dx’s GUIDE-seq off-target NGS analysis technology

webmaster2025-12-23T19:07:07+00:00

HOUSTON, March 2, 2023 /PRNewswire/ -- Avance Biosciences™ (Avance), a leading CRO that provides GLP/CGMP-compliant biological testing services that aid drug development and manufacturing, announced today that it has signed a licensing agreement with SeQure Dx, a cutting-edge gene-editing diagnostics company. This agreement gives Avance access to SeQure Dx’s GUIDE-seq off-target next-generation sequencing (NGS) analysis methods, [...]

Avance Biosciences™ licenses SeQure Dx’s GUIDE-seq off-target NGS analysis technologywebmaster2025-12-23T19:07:07+00:00

28 02, 2023

Quality Assurance of E. coli Cell Banks used in Biopharmaceutical Production
Gallery

Quality Assurance of E. coli Cell Banks used in Biopharmaceutical Production

webmaster2025-12-22T21:15:29+00:00

The use of E. coli cell banks poses some challenges and requires careful attention to quality control and quality assurance to ensure that the cells are of the highest quality and free from contamination or genetic mutations. Testing may include identity, purity, viability, characterization, and stability testing...

Quality Assurance of E. coli Cell Banks used in Biopharmaceutical Productionwebmaster2025-12-22T21:15:29+00:00

27 02, 2023

BioProcess International West – 2023
Gallery

BioProcess International West – 2023

webmaster2025-06-24T14:26:29+00:00

Ensure the Success of Your Biological Drug Development - Avance Provides Assays to Support your Biopharmaceutical Development & Manufacturing - Avance Biosciences™ is a world-leading CRO specializing in GLP & GMP compliant biological assay development, assay validation, and [...]

BioProcess International West – 2023webmaster2025-06-24T14:26:29+00:00

14 02, 2023

mRNA Analytical Development Summit – 2023
Gallery

mRNA Analytical Development Summit – 2023

webmaster2025-12-22T20:41:43+00:00

With several years of experience supporting a world-renowned mRNA COVID-19 vaccine company with raw material and drug substance release, Avance Biosciences™ is well-positioned to provide industry-leading assay design, validation, and sample testing services that advance our clients’ mRNA therapeutic...

mRNA Analytical Development Summit – 2023webmaster2025-12-22T20:41:43+00:00

28 11, 2022

Gene Therapy Analytical Development Summit – 2022
Gallery

Gene Therapy Analytical Development Summit – 2022

webmaster2025-12-22T20:49:42+00:00

Avance offers a broad range of assay development services, including assay design, assay validation, sample testing, and technology transfer under GLP compliance to support IND-enabling and clinical studies. With decades of experience helping gene and cell therapy companies, Avance Biosciences™ has the...

Gene Therapy Analytical Development Summit – 2022webmaster2025-12-22T20:49:42+00:00

22 11, 2022

Quantification of On/Off-Target Gene Editing
Gallery

Quantification of On/Off-Target Gene Editing

webmaster2025-12-22T19:30:47+00:00

Quantitative analysis of gene editing is now an essential step in getting regulatory approval of gene editing-based therapies. But designing and validating assays for on/off-target editing analysis and building an internal team to perform them can be costly and inefficient...

Quantification of On/Off-Target Gene Editingwebmaster2025-12-22T19:30:47+00:00

11 10, 2022

Cell & Gene Meeting on the Mesa – 2022
Gallery

Cell & Gene Meeting on the Mesa – 2022

webmaster2025-12-22T20:51:05+00:00

Avance offers a broad range of assay development services, including assay design, assay validation, sample testing, and technology transfer under GLP compliance to support IND-enabling and clinical studies. With decades of experience helping gene and cell therapy companies, Avance Biosciences™ has the...

Cell & Gene Meeting on the Mesa – 2022webmaster2025-12-22T20:51:05+00:00

27 09, 2022

Biotech Boston – 2022
Gallery

Biotech Boston – 2022

webmaster2025-06-24T14:26:29+00:00

Ensure the Success of Your Biological Drug Development - Avance Provides Assays to Support your Biopharmaceutical Development & Manufacturing - Avance Biosciences™ is a world-leading CRO specializing in GLP & GMP compliant biological assay development, assay validation, and [...]

Biotech Boston – 2022webmaster2025-06-24T14:26:29+00:00

16 02, 2021

Avance Biosciences™ Expanding Houston Campus
Gallery

Avance Biosciences™ Expanding Houston Campus

webmaster2025-12-22T18:22:38+00:00

HOUSTON, Feb. 16, 2021 /PRNewswire/ -- Avance Biosciences™, a leading CRO providing GLP/GMP-compliant assay development, assay validation, and sample testing services supporting biological drug development and manufacturing, announced today that its Houston facility [...]

Avance Biosciences™ Expanding Houston Campuswebmaster2025-12-22T18:22:38+00:00

7 12, 2020

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Company
Gallery

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Company

webmaster2025-10-22T20:54:14+00:00

HOUSTON, Dec. 20, 2020 /-- Pharm Tech Outlook, a highly respected pharmaceutical/biotech industry magazine, has recognized Avance Biosciences™ as a top 10 Genomics Solutions Company for 2020. [...]

Avance Biosciences™ Recognized as Top 10 Genomics Solutions Companywebmaster2025-10-22T20:54:14+00:00

American Assoc. of Pharmaceutical Scientists (AAPS) National Biotechnology Conference – 2025

MIT Engineers Develop Gene Circuit for Precise Control of Gene Therapy

Imiquimod Shows Promise as Immune Enhancer in DNA-Based HIV Vaccine Study

World Vaccine Congress – 2025

US Food and Drug Administration FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

Breakthrough in CAR-T Cell Therapy Offers Hope for B-ALL Treatment